Atul Ltd 2018-19

The goodwill of ` 23.75 cr pertains to the control acquisition of Amal Ltd. The recoverable amount of the cash generating unit has been determined based on the higher of fair value less costs of disposal and its value in use. The fair value less costs of disposal has been determined based on closing quoted share price of Amal Ltd on an active market as on March 31, 2019. During the year a subsidiary company acquired Active Pharma ingredients business of Polydrug Laboratories Pvt Ltd the ĚǊČĚƙƙ ūlj ČūŠƙĿēĚƑîƥĿūŠ ƎîĿē ūǄĚƑ ƥĺĚ ŠĚƥ îƙƙĚƥƙ îČƐƭĿƑĚē ǅîƙ ` 8.56 cr and recognised as goodwill. The Group has carried out impairment assessment as at March 31, 2019 for its all intangible assets. The Management believes ƥĺîƥ îŠǋ ƑĚîƙūŠîċŕǋ ƎūƙƙĿċŕĚ ČĺîŠijĚ ĿŠ ƥĺĚ ŒĚǋ îƙƙƭŞƎƥĿūŠƙ Şîǋ Šūƥ ČîƭƙĚ ƥĺĚ ČîƑƑǋĿŠij îŞūƭŠƥ ƥū ĚǊČĚĚē ƥĺĚ ƑĚČūǄĚƑîċŕĚ amount of the cash generating units. Accordingly, there was no impairment recorded during the year. Note 5 Biological assets a) Biological assets of the Group consists: Ŀȴ TŞŞîƥƭƑĚ ƥĿƙƙƭĚ ČƭŕƥƭƑĚ ƑîĿƙĚē ēîƥĚ ƎîŕŞƙ ƥĺîƥ îƑĚ ČŕîƙƙĿǛĚē îƙ ŠūŠȹČƭƑƑĚŠƥ ċĿūŕūijĿČîŕ îƙƙĚƥƙȦ ¹ĺĚ HƑūƭƎ ĺîƙ î ƎƑūēƭČƥĿūŠ ČǋČŕĚ ūlj îċūƭƥ ljūƭƑȹǛǄĚ ǋĚîƑƙ ĿĿȴ qîƥƭƑĚ ƥĿƙƙƭĚ ČƭŕƥƭƑĚ ƑîĿƙĚē ēîƥĚ ƎîŕŞƙ ƥĺîƥ îƑĚ ČŕîƙƙĿǛĚē îƙ ČƭƑƑĚŠƥ ċĿūŕūijĿČîŕ îƙƙĚƥƙȦ b) Reconciliation of changes to the carrying value of biological assets between the beginning and the end of the current year are as follows: ( ` cr) Particulars Tissue culture raised date palms March 31, 2019 March 31, 2018 Mature Immature Mature Immature Opening balance 11.20 11.50 11.77 9.32 Increase due to production 0.17 11.70 0.18 9.86 Change due to biological transformation 10.05 (10.05) 7.68 (7.68) Decrease due to sale ȳǧǩȦǪǨȴ - ȳǯȦǦǪȴ - Decrease due to write-off (0.13) - (0.05) - Change in fair value due to price changes 1.16 - 0.66 - Closing balance 9.03 13.15 11.20 11.50 Current assets 9.03 - 11.20 - Non-current assets* - 13.15 - 11.50 Biological assets shown in Balance Sheet 9.03 13.15 11.20 11.50 ȜsūŠȹČƭƑƑĚŠƥ ċĿūŕūijĿČîŕ îƙƙĚƥ Ŀƙ ĚǊƎĚČƥĚē ƥū ƥîŒĚ ŞūƑĚ ƥĺîŠ ǧǨ ŞūŠƥĺƙ ljƑūŞ ƑĚƎūƑƥĿŠij ēîƥĚ ƥū ċĚČūŞĚ ƑĚîēǋ ljūƑ ēĿƙƎîƥČĺȦ ƙ îƥ qîƑČĺ ǩǧȡ ǨǦǧǯ ƥĺĚ HƑūƭƎ ĺîē ǧǪȡǩǮǦ ŞîƥƭƑĚ ƎŕîŠƥƙ ȳqîƑČĺ ǩǧȡ ǨǦǧǮȠ ǭȡǯǩǪȴ îŠē ǩȡǪǨȡǭǧǬ ĿŞŞîƥƭƑĚ ƎŕîŠƥƙ ȳqîƑČĺ ǩǧȡ ǨǦǧǮȠ ǪȡǧǪȡǪǩǬȴȦ During current year the Group has sold 1,52,898 plants (March 31, 2018: 1,6 ǭȡǩǪǩȴȦ ( ` cr) Note 6.1 Investments accounted for using the equity method Place of business % of ownership interest As at March 31, 2019 As at March 31, 2018 Investment in equity instruments (fully paid-up) ÀŠƐƭūƥĚē ĿŠǄĚƙƥŞĚŠƥ ĿŠ ŏūĿŠƥ ǄĚŠƥƭƑĚ ČūŞƎîŠǋȠ Rudolf Atul Chemicals Ltd India 50 10.72 10.00 ēēȠ HƑūƭƎ ƙĺîƑĚ ūlj ƎƑūǛƥ ljūƑ ƥĺĚ ǋĚîƑ 5.02 0.72 Total equity accounted investments 15.74 10.72 Consolidated | Notes to the Financial Statements 203